| Year |
Citation |
Score |
| 2023 |
Butts B, Huang H, Hu WT, Kehoe PG, Miners JS, Verble DD, Zetterberg H, Zhao L, Trotti LM, Benameur K, Scorr LM, Wharton W. sPDGFRβ and neuroinflammation are associated with AD biomarkers and differ by race: The ASCEND Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37933404 DOI: 10.1002/alz.13457 |
0.389 |
|
| 2023 |
Giannisis A, Al-Grety A, Carlsson H, Howell JC, Hu WT, Kultima K, Nielsen HM. Correction: Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment. Alzheimer's Research & Therapy. 15: 160. PMID 37759231 DOI: 10.1186/s13195-023-01306-6 |
0.709 |
|
| 2023 |
Giannisis A, Al-Grety A, Carlsson H, Howell JC, Hu WT, Kultima K, Nielsen HM. Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment. Alzheimer's Research & Therapy. 15: 119. PMID 37400888 DOI: 10.1186/s13195-023-01262-1 |
0.737 |
|
| 2023 |
Hu WT, Nayyar A, Kaluzova M. Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 37378862 DOI: 10.1007/s13311-023-01370-8 |
0.459 |
|
| 2023 |
van der Ende EL, In 't Veld SGJG, Hanskamp I, van der Lee S, Dijkstra JIR, Hok-A-Hin YS, Blujdea ER, van Swieten JC, Irwin DJ, Chen-Plotkin A, Hu WT, Lemstra AW, Pijnenburg YAL, van der Flier WM, Del Campo M, et al. CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease. Brain : a Journal of Neurology. PMID 37348871 DOI: 10.1093/brain/awad213 |
0.659 |
|
| 2022 |
Del Campo M, Peeters CFW, Johnson ECB, Vermunt L, Hok-A-Hin YS, van Nee M, Chen-Plotkin A, Irwin DJ, Hu WT, Lah JJ, Seyfried NT, Dammer EB, Herradon G, Meeter LH, van Swieten J, et al. CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nature Aging. 2: 1040-1053. PMID 37118088 DOI: 10.1038/s43587-022-00300-1 |
0.748 |
|
| 2022 |
Chan AWS, Cho IK, Li CX, Zhang X, Patel S, Rusnak R, Raper J, Bachevalier J, Moran SP, Chi T, Cannon KH, Hunter CE, Martin RC, Xiao H, Yang SH, ... ... Hu WT, et al. Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey. Aging Brain. 2. PMID 36589695 DOI: 10.1016/j.nbas.2022.100044 |
0.522 |
|
| 2022 |
Hok-A-Hin YS, Hoozemans JJM, Hu WT, Wouters D, Howell JC, Rábano A, van der Flier WM, Pijnenburg YAL, Teunissen CE, Del Campo M. YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer's disease and frontotemporal lobar degeneration. Alzheimer's Research & Therapy. 14: 100. PMID 35879733 DOI: 10.1186/s13195-022-01039-y |
0.732 |
|
| 2022 |
Hassan A, Mittal SO, Hu WT, Josephs KA, Sorenson EJ, Ahlskog JE. Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis? Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 35170382 DOI: 10.1080/21678421.2022.2039714 |
0.368 |
|
| 2021 |
Wharton W, Jeong L, Ni L, Bay AA, Shin RJ, McCullough LE, Silverstein H, Hart AR, Swieboda D, Hu W, Hackney ME. A Pilot randomized clinical trial of adapted tango to improve cognition and psychosocial function in African American women with family history of Alzheimer's disease (ACT trial). Cerebral Circulation - Cognition and Behavior. 2: 100018. PMID 36324714 DOI: 10.1016/j.cccb.2021.100018 |
0.333 |
|
| 2021 |
Levey AI, Qiu D, Zhao L, Hu WT, Duong DM, Higginbotham L, Dammer EB, Seyfried NT, Wingo TS, Hales CM, Gámez Tansey M, Goldstein DS, Abrol A, Calhoun VD, Goldstein FC, et al. A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain : a Journal of Neurology. PMID 34919634 DOI: 10.1093/brain/awab452 |
0.56 |
|
| 2021 |
Campo MD, Pijnenburg YAL, Chen-Plotkin A, Irwin DJ, Grossman M, Twaalfhoven HAM, Hu WT, Meeter LH, van Swieten J, Vermunt L, Martens F, Heijboer AC, Teunissen CE. Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies. Biomolecules. 11. PMID 34680117 DOI: 10.3390/biom11101484 |
0.692 |
|
| 2021 |
Hu WT, Ozturk T, Kollhoff A, Wharton W, Christina Howell J. Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease. Nature Communications. 12: 4001. PMID 34183654 DOI: 10.1038/s41467-021-24220-7 |
0.411 |
|
| 2021 |
Hu WT, Ozturk T, Kollhoff A, Wharton W, Christina Howell J. Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease. Nature Communications. 12: 4001. PMID 34183654 DOI: 10.1038/s41467-021-24220-7 |
0.411 |
|
| 2021 |
Hassan A, Mittal SO, Hu WT, Josephs KA, Sorenson EJ, Ahlskog JE. Natural History of Pure Primary Lateral Sclerosis. Neurology. PMID 33637635 DOI: 10.1212/WNL.0000000000011771 |
0.331 |
|
| 2020 |
Yilmaz A, Ustun I, Ugur Z, Akyol S, Hu WT, Fiandaca MS, Mapstone M, Federoff H, Maddens M, Graham SF. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning. Journal of Alzheimer's Disease : Jad. PMID 33164929 DOI: 10.3233/JAD-200305 |
0.406 |
|
| 2020 |
Denny A, Streitz M, Stock K, Balls-Berry JE, Barnes LL, Byrd GS, Croff R, Gao S, Glover CM, Hendrie HC, Hu WT, Manly JJ, Moulder KL, Stark S, Thomas SB, et al. Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33034414 DOI: 10.1002/Alz.12160 |
0.397 |
|
| 2020 |
Hu WT, Howell JC, Ozturk T, Benameur K, Bassit LC, Ramonell R, Cashman KS, Pirmohammed S, Roback JD, Marconi VC, Yang I, Mac VV, Smith D, Sanz I, Wharton W, et al. Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020. Emerging Infectious Diseases. 26. PMID 32857691 DOI: 10.3201/Eid2612.203334 |
0.705 |
|
| 2020 |
Benameur K, Agarwal A, Auld SC, Butters MP, Webster AS, Ozturk T, Howell JC, Bassit LC, Velasquez A, Schinazi RF, Mullins ME, Hu WT. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020. Emerging Infectious Diseases. 26. PMID 32487282 DOI: 10.3201/Eid2609.202122 |
0.71 |
|
| 2020 |
Kumar VV, Huang H, Zhao L, Verble DD, Nutaitis A, Tharwani SD, Brown AL, Zetterberg H, Hu W, Shin R, Kehoe PG, Quyyumi A, Nocera J, Kippels A, Wharton W. Baseline Results: The Association between Cardiovascular Risk and Preclinical Alzheimer's Disease Pathology (ASCEND) Study. Journal of Alzheimer's Disease : Jad. PMID 32280088 DOI: 10.3233/Jad-191103 |
0.449 |
|
| 2020 |
Misiura MB, Howell JC, Wu J, Qiu D, Parker MW, Turner JA, Hu WT. Race modifies default mode connectivity in Alzheimer's disease. Translational Neurodegeneration. 9: 8. PMID 32099645 DOI: 10.1186/S40035-020-0186-4 |
0.791 |
|
| 2019 |
Niedzwiecki MM, Walker DI, Howell JC, Watts KD, Jones DP, Miller GW, Hu WT. High-resolution metabolomic profiling of Alzheimer's disease in plasma. Annals of Clinical and Translational Neurology. PMID 31828981 DOI: 10.1002/Acn3.50956 |
0.768 |
|
| 2019 |
Josephs KA, Mackenzie I, Frosch MP, Bigio EH, Neumann M, Arai T, Dugger BN, Ghetti B, Grossman M, Hasegawa M, Herrup K, Holton J, Jellinger K, Lashley T, McAleese KE, ... ... Hu W, et al. LATE to the PART-y. Brain : a Journal of Neurology. PMID 31359030 DOI: 10.1093/Brain/Awz224 |
0.584 |
|
| 2019 |
Wharton W, Kollhoff AL, Gangishetti U, Verble DD, Upadhya S, Zetterberg H, Kumar V, Watts KD, Kippels AJ, Gearing M, Howell JC, Parker MW, Hu WT. IL-9 alterations linked to Alzheimer's disease in African Americans. Annals of Neurology. PMID 31271450 DOI: 10.1002/Ana.25543 |
0.831 |
|
| 2019 |
Ozturk T, Kollhoff A, Anderson AM, Christina Howell J, Loring DW, Waldrop-Valverde D, Franklin D, Letendre S, Tyor WR, Hu WT. Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder. Scientific Reports. 9: 8733. PMID 31217522 DOI: 10.1038/S41598-019-45418-2 |
0.407 |
|
| 2019 |
Hu WT, Howell JC, Ozturk T, Gangishetti U, Kollhoff AL, Hatcher-Martin JM, Anderson AM, Tyor WR. CSF Cytokines in Aging, Multiple Sclerosis, and Dementia. Frontiers in Immunology. 10: 480. PMID 30930904 DOI: 10.3389/Fimmu.2019.00480 |
0.775 |
|
| 2019 |
Bliwise D, Trotti LM, Wood-Siverio C, Hu W. 0712 APOE4, But Not Desaturation Index, Is Associated with Dementia Severity In A Memory Clinic Population Sleep. 42: A285-A286. DOI: 10.1093/Sleep/Zsz067.710 |
0.312 |
|
| 2019 |
Levey AI, Lah JJ, Hu WT, Wingo TS, Hales CM, Manzanares C, Tansey MG, Goldstein DS, Zhao L, Galasko DR, Edland SD, Hanfelt J, Weinshenker D. O4-11-05: A PROOF OF CONCEPT PHASE II STUDY REPURPOSING ATOMOXETINE FOR NEUROPROTECTION IN MILD COGNITIVE IMPAIRMENT: EVIDENCE FOR TARGET ENGAGEMENT, REGULATION OF CSF BIOMARKERS, AND DISEASE-MODIFYING POTENTIAL Alzheimer's & Dementia. 15: P1263-P1264. DOI: 10.1016/J.Jalz.2019.06.4804 |
0.53 |
|
| 2019 |
Wharton W, Kollhoff AL, Gangishetti U, Verble DD, Pak H, Shin R, Huang H, Upadhya S, Zetterberg H, Kumar V, Watts KD, Kippels AJ, Gearing M, Howell J, Parker MW, ... ... Hu WT, et al. O2-02-01: DIFFERENT CSF TOTAL AND PHOSPHORYLATED TAU, BUT NOT Aβ, IN OLDER AND YOUNGER AFRICAN AMERICANS AND WHITES Alzheimer's & Dementia. 15: P535-P535. DOI: 10.1016/J.Jalz.2019.06.4457 |
0.79 |
|
| 2019 |
Misiura M, Howell JC, Parker MW, Turner J, Hu WT. P4-277: DISPARATE RACIAL RELATIONSHIPS BETWEEN COGNITIVE IMPAIRMENT AND FUNCTIONAL CONNECTIVITY IN DEFAULT MODE NETWORK SUBSYSTEMS Alzheimer's & Dementia. 15: P1389-P1389. DOI: 10.1016/J.Jalz.2019.06.3946 |
0.677 |
|
| 2019 |
Hu WT, Wharton W, Kollhoff AL, Gangishetti U, Verble DD, Upadhya S, Zetterberg H, Kumar V, Huang H, Watts KD, Kippels AJ, Gearing M, Howell JC, Parker MW. P3-620: IL-9 ALTERATIONS ARE LINKED TO ALZHEIMER'S DISEASE IN AFRICAN AMERICANS Alzheimer's & Dementia. 15: P1214-P1214. DOI: 10.1016/J.Jalz.2019.06.3658 |
0.799 |
|
| 2019 |
Huang H, Hu WT, Zhao L, Shin R, Verble DD, Howell JC, Pak H, Tharwani S, Kumar V, Flatt J, Anderson JG, Wharton W. P2-598: SUBJECTIVE AND BIOLOGICAL MARKERS OF STRESS IN MIDDLE-AGED CAUCASIAN AND AFRICAN AMERICAN ALZHEIMER'S DISEASE FAMILIES Alzheimer's & Dementia. 15: P853-P853. DOI: 10.1016/J.Jalz.2019.06.3007 |
0.373 |
|
| 2018 |
French CD, Willoughby RE, Pan A, Wong SJ, Foley JF, Wheat LJ, Fernandez J, Encarnacion R, Ondrush JM, Fatteh N, Paez A, David D, Javaid W, Amzuta IG, Neilan AM, ... ... Hu WT, et al. NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system. Plos Neglected Tropical Diseases. 12: e0007045. PMID 30557317 DOI: 10.1371/Journal.Pntd.0007045 |
0.379 |
|
| 2018 |
Allen JW, Yazdani M, Kang J, Magnussen MJ, Qiu D, Hu W. Patients with Mild Cognitive Impairment May be Stratified by Advanced Diffusion Metrics and Neurocognitive Testing. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30548151 DOI: 10.1111/Jon.12588 |
0.317 |
|
| 2018 |
Del Campo M, Galimberti D, Elias N, Boonkamp L, Pijnenburg YA, van Swieten JC, Watts K, Paciotti S, Beccari T, Hu W, Teunissen CE. Novel CSF biomarkers to discriminate FTLD and its pathological subtypes. Annals of Clinical and Translational Neurology. 5: 1163-1175. PMID 30349851 DOI: 10.1002/Acn3.629 |
0.457 |
|
| 2018 |
Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98. PMID 30253800 DOI: 10.1186/S13195-018-0426-3 |
0.833 |
|
| 2018 |
Kollhoff AL, Howell JC, Hu WT. Automation vs. Experience: Measuring Alzheimer's Beta-Amyloid 1-42 Peptide in the CSF. Frontiers in Aging Neuroscience. 10: 253. PMID 30186152 DOI: 10.3389/Fnagi.2018.00253 |
0.742 |
|
| 2018 |
Kamara DM, Gangishetti U, Gearing M, Willis-Parker M, Zhao L, Hu WT, Walker LC. Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29614657 DOI: 10.3233/Jad-170954 |
0.826 |
|
| 2018 |
Trotti LM, Keating G, Bliwise DL, Hu W. 1009 Dementia And Dreaming: Hypocretin Is A Trans-diagnostic Biomarker Of Nightmares In Dementia Sleep. 41: A374-A375. DOI: 10.1093/Sleep/Zsy061.1008 |
0.428 |
|
| 2017 |
Howell JC, Watts KD, Parker MW, Wu J, Kollhoff A, Wingo TS, Dorbin CD, Qiu D, Hu WT. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers. Alzheimer's Research & Therapy. 9: 88. PMID 29096697 DOI: 10.1186/S13195-017-0315-1 |
0.789 |
|
| 2017 |
Hu WT. No doubts about dementia advocacy. The Lancet. Psychiatry. PMID 28986233 DOI: 10.1016/S2215-0366(17)30373-5 |
0.4 |
|
| 2017 |
Gendron TF, Daughrity LM, Heckman MG, Diehl NN, Wuu J, Miller TM, Pastor P, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Benatar M, Silani V, Glass JD, et al. Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis. Annals of Neurology. PMID 28628244 DOI: 10.1002/Ana.24980 |
0.591 |
|
| 2017 |
Gendron TF, Chew J, Stankowski JN, Hayes LR, Zhang YJ, Prudencio M, Carlomagno Y, Daughrity LM, Jansen-West K, Perkerson EA, O'Raw A, Cook C, Pregent L, Belzil V, van Blitterswijk M, ... ... Hu WT, et al. Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Science Translational Medicine. 9. PMID 28356511 DOI: 10.1126/Scitranslmed.Aai7866 |
0.51 |
|
| 2017 |
Tsvetkova DZ, Bergquist SH, Parker MW, Jarrett TL, Howell JC, Watts KD, Kollhoff A, Roberts DL, Hu WT. Fear and Uncertainty Do Not Influence Reported Willingness to Undergo Lumbar Punctures in a U.S. Multi-Cultural Cohort. Frontiers in Aging Neuroscience. 9: 22. PMID 28239349 DOI: 10.3389/Fnagi.2017.00022 |
0.671 |
|
| 2017 |
Hayward D, Howell J, Hu WT. WHAT IS DEMENTIA FRIENDLY? DEVELOPMENT AND VALIDATION OF A NOVEL TOOL TO MEASURE STIGMA ASSOCIATED WITH DEMENTIA Alzheimer's & Dementia. 13: P1514. DOI: 10.1016/J.Jalz.2017.07.633 |
0.716 |
|
| 2017 |
Gangishetti U, Perrin RJ, Arnold SE, Fagan AM, Morris JC, Trojanowski JQ, Hu WT. VALIDATING NON-AMYLOID, NON-TAU CSF BIOMARKERS FOR ALZHEIMER'S DISEASE IN THE PRE-SYMPTOMATIC, MCI, AND DEMENTIA STAGES: A MULTI-CENTER STUDY Alzheimer's & Dementia. 13: P1513-P1514. DOI: 10.1016/J.Jalz.2017.07.632 |
0.836 |
|
| 2016 |
Howell JC, Parker MW, Watts KD, Kollhoff A, Tsvetkova DZ, Hu WT. Research Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience. Frontiers in Aging Neuroscience. 8: 296. PMID 27994549 DOI: 10.3389/Fnagi.2016.00296 |
0.682 |
|
| 2016 |
Holler CJ, Taylor G, McEachin ZT, Deng Q, Watkins WJ, Hudson K, Easley CA, Hu WT, Hales CM, Rossoll W, Bassell GJ, Kukar T. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia. Molecular Neurodegeneration. 11: 46. PMID 27341800 DOI: 10.1186/S13024-016-0114-3 |
0.41 |
|
| 2016 |
Hu WT, Watts KD, Tailor P, Nguyen TP, Howell JC, Lee RC, Seyfried NT, Gearing M, Hales CM, Levey AI, Lah JJ, Lee EK. CSF complement 3 and factor H are staging biomarkers in Alzheimer's disease. Acta Neuropathologica Communications. 4: 14. PMID 26887322 DOI: 10.1186/S40478-016-0277-8 |
0.826 |
|
| 2016 |
Campo MD, Koel-Simmelink MJ, Elias N, Boonkamp L, Galimberti D, Hu WT, Teunissen CE. Novel Csf Biomarkers Discriminating Ftld-Tdp From Non-Demented Controls Alzheimers & Dementia. 12: 388. DOI: 10.1016/J.Jalz.2016.06.731 |
0.36 |
|
| 2016 |
Howell JC, Parker MW, Watts KD, Wingo T, Hu WT. O1-11-06: Lower Prevalence of Abnormal CSF Alzheimer’s Biomarkers Among African Americans than Caucasians with Normal Cognition or Cognitive Impairment Alzheimer's & Dementia. 12: P204-P205. DOI: 10.1016/J.Jalz.2016.06.357 |
0.709 |
|
| 2016 |
Parker MW, Howell J, Dorbin CD, Mouton CP, Hu WT. P4-130: Recruiting Older African Americans for Alzheimer′s Disease Biomarker Study Involving Lumbar Punctures in Two Centers Alzheimer's & Dementia. 12: P1063-P1063. DOI: 10.1016/J.Jalz.2016.06.2221 |
0.717 |
|
| 2016 |
Watts KD, Howell J, Herrera P, Lee RC, Hu WT. P4-123: Resolving Conflicting CSF Biomarker Information in Alzheimer′s Disease Alzheimer's & Dementia. 12: P1061-P1061. DOI: 10.1016/J.Jalz.2016.06.2214 |
0.719 |
|
| 2016 |
Niedzwiecki MM, Walker D, Watts KD, Hu WT. P3-156: Validating Plasma Metabolomics Signatures of Alzheimer’s Disease Alzheimer's & Dementia. 12: P879-P879. DOI: 10.1016/J.Jalz.2016.06.1816 |
0.334 |
|
| 2015 |
Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, et al. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 339-348. PMID 26693175 DOI: 10.1016/J.Dadm.2015.06.008 |
0.739 |
|
| 2015 |
Howell JC, Soyinka O, Parker M, Jarrett TL, Roberts DL, Dorbin CD, Hu WT. Knowledge and Attitudes in Alzheimer's Disease in a Cohort of Older African Americans and Caucasians. American Journal of Alzheimer's Disease and Other Dementias. PMID 26646115 DOI: 10.1177/1533317515619037 |
0.745 |
|
| 2015 |
Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, ... ... Hu WT, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. Brain : a Journal of Neurology. 138: 2701-15. PMID 26220940 DOI: 10.1093/Brain/Awv199 |
0.543 |
|
| 2015 |
Hu WT, Watts KD, Shaw LM, Howell JC, Trojanowski JQ, Basra S, Glass JD, Lah JJ, Levey AI. CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease? Annals of Clinical and Translational Neurology. 2: 131-9. PMID 25750918 DOI: 10.1002/Acn3.160 |
0.797 |
|
| 2015 |
Toledo JB, Zetterberg H, Van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, ... ... Hu WT, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects Brain. 138: 2701-2715. DOI: 10.1093/brain/awv199 |
0.472 |
|
| 2015 |
Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, et al. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 1: 339-348. DOI: 10.1016/j.dadm.2015.06.008 |
0.632 |
|
| 2014 |
Zhang Z, Song M, Liu X, Kang SS, Kwon IS, Duong DM, Seyfried NT, Hu WT, Liu Z, Wang JZ, Cheng L, Sun YE, Yu SP, Levey AI, Ye K. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. Nature Medicine. 20: 1254-62. PMID 25326800 DOI: 10.1038/Nm.3700 |
0.608 |
|
| 2014 |
Grossman M, Elman L, McCluskey L, McMillan CT, Boller A, Powers J, Rascovsky K, Hu W, Shaw L, Irwin DJ, Lee VM, Trojanowski JQ. Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis. Jama Neurology. 71: 442-8. PMID 24492862 DOI: 10.1001/Jamaneurol.2013.6064 |
0.703 |
|
| 2014 |
Johnston JM, Hu WT, Fardo DW, Greco SJ, Perry G, Montine TJ, Trojanowski JQ, Shaw LM, Ashford JW, Tezapsidis N. Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential. Current Alzheimer Research. 11: 165-74. PMID 24359504 DOI: 10.2174/1567205010666131212114156 |
0.564 |
|
| 2014 |
Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, et al. The future of blood-based biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 115-31. PMID 23850333 DOI: 10.1016/J.Jalz.2013.01.013 |
0.568 |
|
| 2013 |
Hu WT, Watts K, Grossman M, Glass J, Lah JJ, Hales C, Shelnutt M, Van Deerlin V, Trojanowski JQ, Levey AI. Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP. Neurology. 81: 1945-52. PMID 24174584 DOI: 10.1212/01.Wnl.0000436625.63650.27 |
0.688 |
|
| 2013 |
Hu WT, Shaw LM, Trojanowski JQ. Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on? Acta Neuropathologica. 126: 625-9. PMID 24154963 DOI: 10.1007/S00401-013-1197-3 |
0.521 |
|
| 2013 |
Yarchoan M, Louneva N, Xie SX, Swenson FJ, Hu W, Soares H, Trojanowski JQ, Lee VM, Kling MA, Shaw LM, Chen-Plotkin A, Wolk DA, Arnold SE. Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease. Journal of the Neurological Sciences. 333: 9-12. PMID 23978419 DOI: 10.1016/J.Jns.2013.05.028 |
0.752 |
|
| 2013 |
Chalermpalanupap T, Kinkead B, Hu WT, Kummer MP, Hammerschmidt T, Heneka MT, Weinshenker D, Levey AI. Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease. Alzheimer's Research & Therapy. 5: 21. PMID 23634965 DOI: 10.1186/Alzrt175 |
0.618 |
|
| 2013 |
Hales CM, Hu WT. From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers. International Review of Psychiatry (Abingdon, England). 25: 210-20. PMID 23611350 DOI: 10.3109/09540261.2013.776522 |
0.453 |
|
| 2013 |
Hu WT, Shelnutt M, Wilson A, Yarab N, Kelly C, Grossman M, Libon DJ, Khan J, Lah JJ, Levey AI, Glass J. Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis. Plos One. 8: e57584. PMID 23460879 DOI: 10.1371/Journal.Pone.0057584 |
0.585 |
|
| 2013 |
Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, et al. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 189-98. PMID 23062850 DOI: 10.1016/J.Jalz.2012.03.003 |
0.513 |
|
| 2013 |
Leung YY, Toledo J, Nefedov A, Polikar R, Raghavan N, Xie S, Farnum M, Schultz T, Baek Y, Lobanov V, DiBernardo A, Deerlin VV, Kling M, Chen-Plotkin A, Mailman M, ... Hu W, et al. Identifying multi-analyte CSF biomarkers for Alzheimer’s disease in a multi-cohort study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.059 |
0.756 |
|
| 2012 |
Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, et al. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology. 79: 897-905. PMID 22855860 DOI: 10.1212/Wnl.0B013E318266Fa70 |
0.801 |
|
| 2012 |
Arnold SE, Xie SX, Leung YY, Wang LS, Kling MA, Han X, Kim EJ, Wolk DA, Bennett DA, Chen-Plotkin A, Grossman M, Hu W, Lee VM, Mackin RS, Trojanowski JQ, et al. Plasma biomarkers of depressive symptoms in older adults. Translational Psychiatry. 2: e65. PMID 22832727 DOI: 10.1038/Tp.2011.63 |
0.716 |
|
| 2012 |
Toledo JB, Brettschneider J, Grossman M, Arnold SE, Hu WT, Xie SX, Lee VM, Shaw LM, Trojanowski JQ. CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. Acta Neuropathologica. 124: 23-35. PMID 22526019 DOI: 10.1007/S00401-012-0983-7 |
0.738 |
|
| 2012 |
Hu W, Basra S, Watts K, Glass J, Lah J, Levey A. Cerebrospinal Fluid beta-Amyloid 1-42 Solubility Is Influenced by Apolipoproteins E and J (S14.002) Neurology. 78: S14.002-S14.002. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S14.002 |
0.482 |
|
| 2012 |
Toledo J, Brettschneider J, Grossman M, Arnold S, Hu W, Xie S, Lee V, Shaw L, Trojanowski J. Improving Diagnostic Accuracy for Dementia: CSF Biomarker Cutoffs Based on Clinical and Neuropathological Criteria (IN3-1.010) Neurology. 78: IN3-1.010-IN3-1.010. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In3-1.010 |
0.608 |
|
| 2012 |
Leung YY, Wang L, Hu WT, Kling M, Wolk D, Trojanowski J, Lee V, Shaw L, Arnold S. P2-049: Cerebrospinal fluid biochemical biomarkers of depressive symptoms in older adults Alzheimer's & Dementia. 8: P280-P280. DOI: 10.1016/J.Jalz.2012.05.2143 |
0.525 |
|
| 2011 |
Hu WT, Trojanowski JQ, Shaw LM. Biomarkers in frontotemporal lobar degenerations--progress and challenges. Progress in Neurobiology. 95: 636-48. PMID 21554923 DOI: 10.1016/J.Pneurobio.2011.04.012 |
0.523 |
|
| 2011 |
Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann Gross R, Hurtig HI, Xie SX, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Van Deerlin VM, Lee VM, et al. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Annals of Neurology. 69: 655-63. PMID 21520231 DOI: 10.1002/Ana.22271 |
0.724 |
|
| 2011 |
Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL, Brooks WS, Halliday GM, Kril JJ, et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Archives of Neurology. 68: 488-97. PMID 21482928 DOI: 10.1001/Archneurol.2011.53 |
0.753 |
|
| 2011 |
Vass R, Ashbridge E, Geser F, Hu WT, Grossman M, Clay-Falcone D, Elman L, McCluskey L, Lee VM, Van Deerlin VM, Trojanowski JQ, Chen-Plotkin AS. Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathologica. 121: 373-80. PMID 21104415 DOI: 10.1007/S00401-010-0782-Y |
0.715 |
|
| 2011 |
Soares H, Potter W, Immermann F, Pickering E, Kuhn M, Shera D, Zagouras P, Swenson F, Wan H, Ferm M, Siuciak J, Koroshetz W, Simon A, Lee V, Buckholtz N, ... Hu W, et al. Changes in plasma based biomarkers in Alzheimer's disease, mild cognitively impaired and aged matched normal controls from the ADNI cohort Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.960 |
0.639 |
|
| 2011 |
Arnold S, Xie SX, Leung Y, Kim E, Kling M, Wilson R, Bennett D, Hu W, Mackin S, Grossman M, Chen-Plotkin A, Wolk D, Lee V, Trojanowski J, Shaw L. P2-017: Biochemical Biomarkers of Depressive Symptoms in ADNI Alzheimer's & Dementia. 7: S312-S312. DOI: 10.1016/J.Jalz.2011.05.907 |
0.691 |
|
| 2011 |
Hu WT, Holtzman D, Clark C, Grossman M, Karlawish J, Fagan A, Lee V, Swenson F, Craig-Schapiro R, Perrin RJ, Soares H, Trojanowski J, Xiong C, Morris J, Shaw L, et al. P1-089: Plasma multianalyte profiling of mild cognitive impairment and Alzheimer's disease in two academic centers and the Alzheimer's Disease Neuroimaging Initiative Alzheimer's & Dementia. 7: S138-S138. DOI: 10.1016/J.Jalz.2011.05.368 |
0.781 |
|
| 2010 |
Hu WT, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, McCluskey L, Elman L, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ. Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology. 75: 2079-86. PMID 21048198 DOI: 10.1016/J.Jalz.2010.05.253 |
0.771 |
|
| 2010 |
Hu WT, Wang Z, Lee VM, Trojanowski JQ, Detre JA, Grossman M. Distinct cerebral perfusion patterns in FTLD and AD. Neurology. 75: 881-8. PMID 20819999 DOI: 10.1212/Wnl.0B013E3181F11E35 |
0.663 |
|
| 2010 |
Hu WT, McMillan C, Libon D, Leight S, Forman M, Lee VM, Trojanowski JQ, Grossman M. Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology. 75: 595-602. PMID 20713948 DOI: 10.1212/Wnl.0B013E3181Ed9C52 |
0.823 |
|
| 2010 |
Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ. Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathologica. 120: 385-99. PMID 20652578 DOI: 10.1007/S00401-010-0723-9 |
0.808 |
|
| 2010 |
Josephs KA, Whitwell JL, Boeve BF, Knopman DS, Petersen RC, Hu WT, Parisi JE, Dickson DW, Jack CR. Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1246-52. PMID 20629131 DOI: 10.1002/Mds.23062 |
0.646 |
|
| 2010 |
Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, Pickering E, Kuhn M, Chen Y, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, et al. Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment. Acta Neuropathologica. 119: 669-78. PMID 20232070 DOI: 10.1007/S00401-010-0667-0 |
0.798 |
|
| 2010 |
Hu WT, Grossman M, Chen-Plotkin A, Arnold SE, Clark CM, Shaw LM, Lee VM, Soares HD, Trojanowski JQ. O1-07-05: Novel CSF biomarkers for frontotemporal lobar degenerations Alzheimer's & Dementia. 6: S84-S84. DOI: 10.1016/j.jalz.2010.05.253 |
0.661 |
|
| 2010 |
Soares H, Hu W, Grossman M, Clark C, Pickering E, Chen Y, Kuhn M, Chen-Plotkin A, Arnold S, Shaw L, Lee VM, Swenson F, Trojanowski JQ. P2-093: Multiplex plasma panels as screening tools in Alzheimer's disease. Alzheimer's & Dementia. 6: S340-S340. DOI: 10.1016/J.Jalz.2010.05.1139 |
0.718 |
|
| 2009 |
Hu WT, Seelaar H, Josephs KA, Knopman DS, Boeve BF, Sorenson EJ, McCluskey L, Elman L, Schelhaas HJ, Parisi JE, Kuesters B, Lee VM, Trojanowski JQ, Petersen RC, van Swieten JC, et al. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Archives of Neurology. 66: 1359-64. PMID 19901167 DOI: 10.1001/Archneurol.2009.253 |
0.751 |
|
| 2009 |
Hu WT, Grossman M. TDP-43 and frontotemporal dementia. Current Neurology and Neuroscience Reports. 9: 353-8. PMID 19664364 DOI: 10.1007/S11910-009-0052-3 |
0.568 |
|
| 2009 |
Hu WT, Rippon GW, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Josephs KA. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1375-9. PMID 19425061 DOI: 10.1002/Mds.22574 |
0.683 |
|
| 2008 |
Hu WT, Josephs KA, Knopman DS, Boeve BF, Dickson DW, Petersen RC, Parisi JE. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathologica. 116: 215-20. PMID 18592255 DOI: 10.1007/S00401-008-0400-4 |
0.647 |
|
| 2008 |
Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M, Rademakers R, Boeve BF, Parisi JE, Smith GE, Ivnik RJ, Petersen RC, Jack CR, Dickson DW. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology. 70: 1850-7. PMID 18401022 DOI: 10.1212/01.Wnl.0000304041.09418.B1 |
0.673 |
|
| 2008 |
Josephs KA, Whitwell JL, Duffy JR, Vanvoorst WA, Strand EA, Hu WT, Boeve BF, Graff-Radford NR, Parisi JE, Knopman DS, Dickson DW, Jack CR, Petersen RC. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology. 70: 25-34. PMID 18166704 DOI: 10.1212/01.Wnl.0000287073.12737.35 |
0.684 |
|
| 2008 |
Hu WT, Rippon GA, Boeve BF, Parisi JE, Knopman DS, Petersen RC, Josephs KA. P3-018: Alzheimer's disease presenting as corticobasal syndrome Alzheimer's & Dementia. 4: T521-T522. DOI: 10.1016/J.Jalz.2008.05.1581 |
0.652 |
|
| 2007 |
Hu WT, Parisi JE, Knopman DS, Boeve BF, Dickson DW, Ahlskog JE, Petersen RC, Josephs KA. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia. Alzheimer Disease and Associated Disorders. 21: S39-43. PMID 18090422 DOI: 10.1097/Wad.0B013E31815Bf5E5 |
0.574 |
|
| 2007 |
Hu WT, Mandrekar JN, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Hutton M, Dickson DW, Josephs KA. Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia. Archives of Neurology. 64: 1611-6. PMID 17998443 DOI: 10.1001/Archneur.64.11.1611 |
0.635 |
|
| 2007 |
Hu WT, Josephs KA, Dickson DW, Knopman DS, Boeve BF, Petersen RC, Parisi JE. Dual pathologies: utility of TAR DNA-binding protein 43 (TDP-43) staining in patients with frontal and temporal lobe abnormalities and Alzheimer disease Journal of Neuropathology and Experimental Neurology. 66: 421. DOI: 10.1096/Fasebj.21.5.A21-A |
0.631 |
|
| 2007 |
Hu WT, Josephs KA, Dickson DW, Knopman DS, Boeve BF, Petersen RC, Parisi JE. Dual pathologies: Utility of TAR DNA‐binding Protein 43 (TDP‐43) Staining in Patients with Frontal and Temporal Lobe Abnormalities and Alzheimer disease The Faseb Journal. 21. DOI: 10.1096/FASEBJ.21.5.A21-A |
0.618 |
|
| 2006 |
Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA. Cognitive impairment and celiac disease. Archives of Neurology. 63: 1440-6. PMID 17030661 DOI: 10.1001/Archneur.63.10.1440 |
0.627 |
|
| 2006 |
Misiura M, Hu WT, Turner J, Howell JC. IC-P-039: RACE MODIFIES FUNCTIONAL CONNECTIVITY OF THE DEFAULT MODE NETWORK IN AGING AND ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P40-P41. DOI: 10.1016/J.Jalz.2018.06.2103 |
0.708 |
|
| 2006 |
Misiura M, Hu WT, Turner J, Howell JC. P1-008: RACE MODIFIES FUNCTIONAL CONNECTIVITY OF THE DEFAULT MODE NETWORK IN AGING AND ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P265-P265. DOI: 10.1016/j.jalz.2018.06.009 |
0.697 |
|
| 2005 |
Hu WT, Josephs KA, Ahlskog JE, Shin C, Boeve BF, Witte RJ. MRI correlates of alien leg-like phenomenon in corticobasal degeneration. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 870-3. PMID 15799014 DOI: 10.1002/Mds.20451 |
0.449 |
|
| 2005 |
Hu WT, Petersen RC. [P-071]: Use of angiotensin converting enzyme inhibitors and age of Alzheimer's disease onset in patients with the Apolipoprotein E ϵ4 allele Alzheimer's & Dementia. 1: S30-S30. DOI: 10.1016/J.Jalz.2005.06.145 |
0.374 |
|
| 2003 |
Hu W, Gray NW, Brimijoin S. Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. Journal of Neurochemistry. 86: 470-8. PMID 12871588 DOI: 10.1046/J.1471-4159.2003.01855.X |
0.357 |
|
| Show low-probability matches. |